Skip to content

All recalls FDA

FDADrugsRecalled Status: Closed by the agency

AvKARE recalls Atovaquone Oral Suspension USP

Class Iofficial

FDA Class I

FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.

Hazard
Microbial contamination of a non-sterile product: potential Bacillus cereus contamination.
Products
  • Atovaquone Oral Suspension USP
Company
AvKARE
Where it was sold

US Nationwide.

Nationwide

Units affected
153 cartons
About this recall
Atovaquone Oral Suspension USP, 750 mg per 5 mL sachets, 20 Units x 5 mL cartons, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478, NDC 50268-086-12.